Araştırma özeti
Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by
BackgroundDepression in Parkinson's disease (dPD) is common and heterogeneous, impairs quality of life, and may accelerate disease progression. Tools that predict long-term dPD progression are lacking.MethodsWe retrospectively analyzed de novo, drug-naïve Parkinson's disease (PD) participants in the Parkinson's Progression Markers Initiative (PPMI; 2011-2024). The primary outcome was depressive progression, defined as a sustained worsening in Geriatric Depression Scale-15 (GDS-15) category over 12 months. Candidate predictors included demographic, motor, and non-motor variables at both total and sub-item levels. Four survival machine learning models, Random Survival Forests (RSF), Extreme Gradient Boosting, Support Vector Survival Machines, and Gradient Boosting Survival Analysis, were evaluated using concordance index (C-index). Shapley Additive exPlanations were applied to identify key predictors and construct an integer-based risk score.ResultsOf 1819 eligible participants, 496 met inclusion criteria (median age 62 years [IQR: 55-69]; 61.3% male); 94 (19.0%) progressed over a median 6 year follow-up. RSF achieved the best discrimination (test-set C-index 0.744). Key predictors included age, baseline GDS-15; SCOPA-AUT subscores (thermoregulatory, gastrointestinal, cardiovascular); cognition (BJLOT, SDMT); impulse control disorder (QUIP-CS score), and MDS-UPDRS I (sleep problems night, pain and other sensations). The SHAP-derived score stratified patients into low (progression 7.3%), moderate (14.7%), and high-risk (36.5%) groups with clear Kaplan-Meier separation (log-rank p ConclusionsAn explainable survival model and integer-based risk score using routinely collected measures predicted long-term dPD progression and enabled pragmatic risk stratification to support early, personalized management.
Bilimsel değerlendirme
Araştırma sorusu
Sorunun kapsamı orijinal çalışma üzerinden değerlendirilir.
Yöntem ve örneklem
Çalışma tasarımı ve örneklem için kaynak makaleyi kontrol edin.
Temel bulgular
Bu kayıt için editoryal olarak onaylanmış bulgu özeti henüz yayımlanmadı.
Sınırlılıklar
Sonuçların genellenebilirliği, yanlılık ve klinik anlamı ayrıca incelenmelidir.
Bibliyografik veriden yöntem, örneklem veya klinik sonuç çıkarımı yapılmaz.